419 related articles for article (PubMed ID: 26528763)
1. Central Precocious Puberty: Adult Height in Girls Treated with Quarterly or Monthly Gonadotropin-Releasing Hormone Analog Triptorelin.
Bertelloni S; Massart F; Einaudi S; Wasniewska M; Miccoli M; Baroncelli GI
Horm Res Paediatr; 2015; 84(6):396-400. PubMed ID: 26528763
[TBL] [Abstract][Full Text] [Related]
2. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
3. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
[TBL] [Abstract][Full Text] [Related]
4. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
Lanes R; Soros A; Jakubowicz S
J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
[TBL] [Abstract][Full Text] [Related]
5. Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.
Bertelloni S; Mucaria C; Baroncelli GI; Peroni D
Expert Rev Clin Pharmacol; 2018 Jul; 11(7):659-667. PubMed ID: 29957076
[TBL] [Abstract][Full Text] [Related]
6. Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty.
Yoo E; Kim S; Jung HL; Shim JY; Shim JW; Kim DS; Kwak JH; Kim ES; Yang A
Front Endocrinol (Lausanne); 2023; 14():1134977. PubMed ID: 36875449
[TBL] [Abstract][Full Text] [Related]
7. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
Pucarelli I; Segni M; Ortore M; Arcadi E; Pasquino AM
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
[TBL] [Abstract][Full Text] [Related]
8. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment].
Messaaoui A; Massa G; Tenoutasse S; Heinrichs C
Rev Med Brux; 2005 Feb; 26(1):27-32. PubMed ID: 15816337
[TBL] [Abstract][Full Text] [Related]
10. [Triptorelin therapy in girls with central precocious puberty increases body mass index].
Martín Díaz MJ; Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Argente Oliver J
An Pediatr (Barc); 2006 Nov; 65(5):428-33. PubMed ID: 17184602
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin releasing hormone agonist treatment for central precocious puberty.
Carel JC; Chaussain JL
Horm Res; 1999; 51 Suppl 3():64-9. PubMed ID: 10592446
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study.
Luo X; Zhang C; Yang Y; Xu X; Cheng X; Wei H; Wang L; Huang F; Shi X; Cabri P
Adv Ther; 2023 Oct; 40(10):4574-4588. PubMed ID: 37584898
[TBL] [Abstract][Full Text] [Related]
13. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
Gómez F; Picó AM; Vargas F; Mauri M
Med Clin (Barc); 1996 Nov; 107(18):681-4. PubMed ID: 9082075
[TBL] [Abstract][Full Text] [Related]
14. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.
Oostdijk W; Drop SL; Odink RJ; Hümmelink R; Partsch CJ; Sippell WG
Acta Paediatr Scand Suppl; 1991; 372():39-45; discussion 46. PubMed ID: 1833950
[TBL] [Abstract][Full Text] [Related]
15. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.
Carel JC; Roger M; Ispas S; Tondu F; Lahlou N; Blumberg J; Chaussain JL
J Clin Endocrinol Metab; 1999 Jun; 84(6):1973-8. PubMed ID: 10372696
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
J Korean Med Sci; 2021 Aug; 36(34):e219. PubMed ID: 34463062
[TBL] [Abstract][Full Text] [Related]
17. Near final height after GnRH agonist treatment in central precocious puberty.
Micillo M; Salerno M; Officioso A; Perna E; Gasparini N; Pisaturo L; Di Maio S
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():787-90. PubMed ID: 10969922
[TBL] [Abstract][Full Text] [Related]
18. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
19. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
Hofmann-Ehrhart B; Schulz U; Kluge M; Wandl-Vergesslich K; Waldhauser F
Wien Klin Wochenschr; 1995; 107(14):413-7. PubMed ID: 7668000
[TBL] [Abstract][Full Text] [Related]
20. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
